iSpecimen Inc.
ISPCCIK 0001558569
Revenue (TTM)
$10.59M
−4.6% YoY
Q1 May 2026
Net Income (TTM)
−$7.76M
+16.1% YoY
Q1 May 2026
EPS Diluted (TTM)
−$36.11
+87.0% YoY
Q1 May 2026
Gross Margin
83.8%
Q1 May 2026
Operating Margin
-83.3%
Q1 May 2026
Net Margin
-73.3%
Q1 May 2026
Free Cash Flow (TTM)
−$9.36M
Q1 May 2026
Cash
$2.82M
Q1 May 2026
Total Debt
$4.43M
Q1 May 2026
Shares Outstanding
1.44M sh
Q1 May 2026